The cluster is too small and board-driven to signal a material bearish view. Per academic literature, cluster sales are not strongly informative absent C-suite participation, and these sales directly follow director equity grants, typical diversification. No immediate trading action warranted; monitor for any C-suite selling or a material increase in volume.
QURE drugs
QURE drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 15 $27.87entry
- T+1 · 5mo ago −3.16%α −2.56% · $26.99
- T+5 · 5mo ago +59.28%α +60.66% · $44.39
- T+20 · 4mo ago +47.47%α +48.22% · $41.10
- T+60 · 2mo ago +65.05%α +64.05% · $46.00
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Six uniQure insiders (five directors and the chief customer & strategy officer) sold a total of $701K in open-market sales on June 11, 2026, at $27.06/share. The cluster is overwhelmingly board-level, with no C-suite trading beyond a single non-CEO officer, and the total value represents ~0.04% of the $1.7B market cap, well below the 0.1% materiality threshold. The prior day's non-cash grants to the same directors suggest these sales are routine diversification following equity vesting/awards, not an informed negative signal.
Key Financial Metrics
Key Facts
- Total insider sales: $701K (0.04% of $1.7B market cap)
- Five directors each sold ~$54K; one officer sold $431K
- Prior day (June 10): same directors received non-cash equity grants, sales appear diversification-driven
- No CEO, CFO, or CSO participation in the selling
- Stock traded at ~$27.06, near recent levels; no material price movement tied to these sales
Financial Impact
6 insiders sold $701K total, or 0.04% of market cap, trivial relative to company size
Risk Factors
- If C-suite insiders (CEO, CFO) begin selling in the coming weeks, the signal would escalate
- Grant-and-sell patterns can repeat quarterly, watch next grant cycle for similar disposition
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-QURE-1781301394963 |
Track record
38 reports on QURE
6 of 11 bullish or bearish reports moved the stock their way by T+1. Best: +27.15% at T+20 after the Jul 29, 2026 report. 8 of 11 went positive at some point.
Filters
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $22.79 to $22.71 Now $21.88 −3.99% ▼ −0.35% +0.02% vs SPY
- Nov 4, 202612d ago 8-K Bullish 7/10 No price data
- Nov 4, 202612d ago Press Release Neutral 6/10 Entry $23.03 to $21.01 Now $21.88 −4.99% ▼ −8.77% −4.36% vs SPY
- Nov 2, 202614d ago 8-K Bullish 7/10 Entry $22.97 to $23.87 Now $21.88 −4.75% ▲ +3.92% +3.62% vs SPY
- Nov 2, 202614d ago Press Release Bullish 7/10 Entry $22.97 to $23.87 Now $21.88 −4.75% ▲ +3.92% +3.62% vs SPY
- Oct 16, 20264w ago SC 13G/A Neutral 3/10 Entry $21.78 to $22.20 Now $21.88 +0.46% ▲ +1.93% +1.51% vs SPY
- Sep 2, 202610w ago 8-K Bullish 7/10 Entry $46.23 to $44.86 Now $21.88 −52.67% ▼ −2.96% −4.01% vs SPY
- Jul 29, 202615w ago 8-K Bullish 8/10 Entry $40.07 to $42.19 Now $21.88 −45.40% ▲ +5.29% +3.61% vs SPY
- Jul 7, 202619w ago Insider Cluster Bearish 5/10 Entry $41.41 to $43.49 Now $21.88 +47.16% ▼ −5.02% −5.33% vs SPY
- Jul 2, 202619w ago Insider Cluster Bearish 4/10 Entry $41.81 to $41.36 Now $21.88 +47.67% ▲ +1.08% +1.95% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers